Gentamicin Sulfate 10 mg Injection bulk supplier for pharma manufacturers

Gentamicin Sulfate 10 Mg Injection 10 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IV, IM)

Available Strengths: 10 mg/mL

Reference Brands: Genoptic(US)

Gentamicin sulfate injection works by binding to bacterial ribosomes, disrupting protein synthesis and causing bacterial death. It is effective against Gram-negative and some Gram-positive bacteria. Benefits include rapid, broad-spectrum action, treating severe infections, reducing bacterial load, and supporting quick recovery when used appropriately under veterinary supervision.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Gentamicin sulfate injection is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval involves rigorous clinical data and safety evaluations, while in the EU, CE marking certifies conformity with veterinary and medicinal regulations. These products undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective gentamicin formulations for treating severe bacterial infections in animals worldwide.

Gentamicin Sulfate 10 Mg Injection — third party manufacturing & bulk supply

Gentamicin Sulfate 10 Mg Injection 10 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gentamicin Sulfate 10 Mg Injection is supplied as Injectable solution (IV, IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gentamicin Sulfate 10 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gentamicin Sulfate 10 Mg Injection →

Back to Listing

Frequently Asked Questions

Gentamicin injection is used for the treatment of serious bacterial infections in animals caused by susceptible Gram-negative and certain Gram-positive organisms. It is commonly prescribed for septicemia, respiratory tract infections, urinary tract infections, gastrointestinal infections, soft tissue infections, and musculoskeletal infections.

Gentamicin injection is made from gentamicin sulfate, an aminoglycoside antibiotic that works by irreversibly binding to the 30S ribosomal subunit of bacteria, inhibiting protein synthesis, and leading to bacterial cell death.

Common trade names include Gentacin Injection, Garamycin Injection, and other generic formulations used in veterinary practice.

Gentamicin injection is manufactured by multiple veterinary and pharmaceutical companies worldwide, including Zoetis, Intas Pharmaceuticals, Virbac, and other generic manufacturers.

The generic name is gentamicin sulfate injection.

Brand names include Gentacin Injection, Garamycin Injection, and other region-specific generics.

Gentamicin injection is manufactured globally, with major production in India, Europe, and the United States by veterinary-focused pharmaceutical companies.